Cargando…
In vitro Antitumor Activity, Intracellular Accumulation, and DNA Adduct Formation of cis‐[((1R, 2R)‐1,2‐Cyclohexanediamine‐N, N')bis(myristato)] Platinum (II) Suspended in Lipiodol
SM‐11355, cis‐[((1R,2R)‐1,2‐cyclohexanediamine‐N,N')bis(myristato)] platinum (II), is a lipophilic platinum complex under clinical development that targets primary hepatocellular carcinoma using Lipiodol as a carrier. SM‐11355 was compared with cisplatin (CDDP) using an in vitro evaluation syst...
Autores principales: | Kishimoto, Shuichi, Miyazawa, Kenji, Fukushima, Shoji, Takeuchi, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926231/ https://www.ncbi.nlm.nih.gov/pubmed/10744050 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00865.x |
Ejemplares similares
-
Cytotoxicity of cis‐[((1R,2R)‐1,2‐Cyclohexanediamine‐N,N')bis(myristato)]‐platinum (II) Suspended in Lipiodol in a Newly Established Cisplatinresistant Rat Hepatoma Cell Line
por: Kishimoto, Shuichi, et al.
Publicado: (2000) -
Functional Cis-Heterodimers of N- and R-Cadherins
por: Shan, Wei-Song, et al.
Publicado: (2000) -
Asymmetric Michael addition reactions catalyzed by calix[4]thiourea cyclohexanediamine derivatives
por: Li, Zheng-Yi, et al.
Publicado: (2018) -
cis-Bis(2-sulfidopyridine N-oxide)platinum(II)
por: Ravindran Durai Nayagam, B., et al.
Publicado: (2008) -
cis-Dichloridobis(N,N,N′,N′-tetramethylethane-1,2-diamine)platinum(II)
por: Asiri, Abdullah M., et al.
Publicado: (2012)